
Domril 10mg Tablet DT
Marketer
Monokem Labs
Salt Composition
Domperidone (10mg)
Overview Domril 10mg Tablet DT
Motilium 10mg Delayed-Release Tablets are indicated for managing indigestion, nausea, and vomiting. This medication accelerates gastrointestinal transit, alleviating symptoms such as bloating, satiety, and stomach upset. Administer one 10mg tablet thirty minutes prior to each meal, following the physician's prescribed dosage and duration. Your individual dose will be determined by your health status and treatment response. Continue treatment as directed by your doctor. Inform your doctor of all other medications you are currently using, as interactions may occur. Commonly reported side effects include headache, dry mouth, and abdominal pain; these are typically transient and self-limiting. Report any concerns regarding side effects to your doctor immediately. Drowsiness may occur; refrain from driving or operating machinery until the effects of the medicine are known. Alcohol consumption should be avoided due to potential exacerbation of side effects. Diarrhea is a possibility; increased fluid intake is recommended to prevent dehydration. Prior to initiating treatment, disclose any pre-existing liver or kidney conditions to your physician. Concurrent use with antacids should be avoided. Pregnant individuals should seek medical counsel before use. This medicine is contraindicated in patients with active peptic ulcers.
Uses of Domril 10mg Tablet DT
Managing indigestion, nausea, and vomiting.
Major Benefits of Domril 10mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Domril 10mg Tablet DT in water before consumption. Administer on an empty stomach.
Common Side effects of Domril 10mg Tablet DT:
- Headache
- Dryness in mouth
- Stomach pain
- Diarrhea
How to use Domril 10mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Domril 10mg Tablet DT in water before consumption. Administer on an empty stomach.
How Domril 10mg Tablet DT works:
Navoban 10mg Delayed-Release Tablets stimulate gastrointestinal motility. Their mechanism involves central action on the brain's emetic center, and peripheral effects accelerating stomach and intestinal transit, thereby facilitating food passage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Domril 10mg Tablet DT has not been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Domril 10mg Delayed-Release Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with the use of Domril 10mg Delayed-Release Tablets. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Taking a Domril 10mg Tablet DT might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Domril 10mg Tablet DT cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Domril 10mg Tablet DT, as dose modification may be necessary. Consult a physician before use. Domril 10mg Tablet DT is contraindicated for patients exhibiting moderate to severe liver disease.
What if you forget to take Domril 10mg Tablet DT :
Should you forget a Domril 10mg Tablet DT dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid doubling the prescribed dose.
Facts to Know About Domril 10mg Tablet DT
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Prokinetic agent with dopamine (D2) receptor antagonism |
